← Open Payments lookup

EDWARD MIKULA: Open Payments

NPI 1639506165 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,071 in 93 payments from 21 companies in 2025. Trend: 2023 $2,482 · 2024 $2,592 · 2025 $2,071

Food & beverage: $2,071
CompanyPaymentsAmount
PFIZER INC.12$242
Novartis Pharmaceuticals Corporation12$223
Boehringer Ingelheim Pharmaceuticals, Inc.10$205
Amgen Inc.8$192
E.R. Squibb & Sons, L.L.C.8$142
Alnylam Pharmaceuticals Inc.5$141
Abbott Laboratories1$135
SCPHARMACEUTICALS INC.6$106
Boston Scientific Corporation3$95
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)6$93

Products named: LEQVIO, ELIQUIS, JARDIANCE, REPATHA, AMVUTTRA, JOT DX, FUROSCIX, WATCHMAN FLX.

Industry payments across MD — which companies pay providers there.